These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36428153)

  • 41. Extracellular Loop 2 of the Adenosine A1 Receptor Has a Key Role in Orthosteric Ligand Affinity and Agonist Efficacy.
    Nguyen AT; Baltos JA; Thomas T; Nguyen TD; Muñoz LL; Gregory KJ; White PJ; Sexton PM; Christopoulos A; May LT
    Mol Pharmacol; 2016 Dec; 90(6):703-714. PubMed ID: 27683014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
    Laumonnier Y; Karsten CM; Köhl G; Köhl J
    Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gaussian accelerated molecular dynamics (GaMD): principles and applications.
    Wang J; Arantes PR; Bhattarai A; Hsu RV; Pawnikar S; Huang YM; Palermo G; Miao Y
    Wiley Interdiscip Rev Comput Mol Sci; 2021; 11(5):. PubMed ID: 34899998
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular Mechanisms of Diverse Activation Stimulated by Different Biased Agonists for the β2-Adrenergic Receptor.
    Chen J; Liu J; Yuan Y; Chen X; Zhang F; Pu X
    J Chem Inf Model; 2022 Nov; 62(21):5175-5192. PubMed ID: 34802238
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Replica Exchange Gaussian Accelerated Molecular Dynamics: Improved Enhanced Sampling and Free Energy Calculation.
    Huang YM; McCammon JA; Miao Y
    J Chem Theory Comput; 2018 Apr; 14(4):1853-1864. PubMed ID: 29489349
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of complement C5a in mechanical inflammatory hypernociception: potential use of C5a receptor antagonists to control inflammatory pain.
    Ting E; Guerrero AT; Cunha TM; Verri WA; Taylor SM; Woodruff TM; Cunha FQ; Ferreira SH
    Br J Pharmacol; 2008 Mar; 153(5):1043-53. PubMed ID: 18084313
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complement C5a Receptor 1 Exacerbates the Pathophysiology of
    Herrmann JB; Muenstermann M; Strobel L; Schubert-Unkmeir A; Woodruff TM; Gray-Owen SD; Klos A; Johswich KO
    mBio; 2018 Jan; 9(1):. PubMed ID: 29362231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity.
    Gorman DM; Li XX; Lee JD; Fung JN; Cui CS; Lee HS; Rolfe BE; Woodruff TM; Clark RJ
    J Med Chem; 2021 Nov; 64(22):16598-16608. PubMed ID: 34762432
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists.
    Li XX; Clark RJ; Woodruff TM
    Int Immunopharmacol; 2021 Nov; 100():108074. PubMed ID: 34454293
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Accurate calculation of absolute free energy of binding for SHP2 allosteric inhibitors using free energy perturbation.
    Liang L; Liu H; Xing G; Deng C; Hua Y; Gu R; Lu T; Chen Y; Zhang Y
    Phys Chem Chem Phys; 2022 May; 24(17):9904-9920. PubMed ID: 35416820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. GLOW: A Workflow Integrating Gaussian-Accelerated Molecular Dynamics and Deep Learning for Free Energy Profiling.
    Do HN; Wang J; Bhattarai A; Miao Y
    J Chem Theory Comput; 2022 Mar; 18(3):1423-1436. PubMed ID: 35200019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phagocytosis of live and dead Escherichia coli and Staphylococcus aureus in human whole blood is markedly reduced by combined inhibition of C5aR1 and CD14.
    Skjeflo EW; Christiansen D; Landsem A; Stenvik J; Woodruff TM; Espevik T; Nielsen EW; Mollnes TE
    Mol Immunol; 2019 Aug; 112():131-139. PubMed ID: 31102985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigating the mechanism of recognition and structural dynamics of nucleoprotein-RNA complex from
    Roy R; Mishra A; Poddar S; Nayak D; Kar P
    J Biomol Struct Dyn; 2022 Mar; 40(5):2302-2315. PubMed ID: 33089759
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Complement System Component C5a Produces Thermal Hyperalgesia via Macrophage-to-Nociceptor Signaling That Requires NGF and TRPV1.
    Shutov LP; Warwick CA; Shi X; Gnanasekaran A; Shepherd AJ; Mohapatra DP; Woodruff TM; Clark JD; Usachev YM
    J Neurosci; 2016 May; 36(18):5055-70. PubMed ID: 27147658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. C5aR2 receptor: The genomic twin of the flamboyant C5aR1.
    Das A; Gupta PK; Rana S
    J Cell Biochem; 2022 Nov; 123(11):1841-1856. PubMed ID: 35977039
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.
    Colley CS; Popovic B; Sridharan S; Debreczeni JE; Hargeaves D; Fung M; An LL; Edwards B; Arnold J; England E; Eghobamien L; Sivars U; Flavell L; Renshaw J; Wickson K; Warrener P; Zha J; Bonnell J; Woods R; Wilkinson T; Dobson C; Vaughan TJ
    MAbs; 2018 Jan; 10(1):104-117. PubMed ID: 28952876
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Investigating detailed interactions between novel PAR1 antagonist F16357 and the receptor using docking and molecular dynamic simulations.
    Readmond C; Wu C
    J Mol Graph Model; 2017 Oct; 77():205-217. PubMed ID: 28881236
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Allosteric Modulators Enhancing GLP-1 Binding to GLP-1R via a Transmembrane Site.
    Wang J; Yang D; Cheng X; Yang L; Wang Z; Dai A; Cai X; Zhang C; Yuliantie E; Liu Q; Jiang H; Liu H; Wang MW; Yang H
    ACS Chem Biol; 2021 Nov; 16(11):2444-2452. PubMed ID: 34570476
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Binding Analysis Using Accelerated Molecular Dynamics Simulations and Future Perspectives.
    Pawnikar S; Bhattarai A; Wang J; Miao Y
    Adv Appl Bioinform Chem; 2022; 15():1-19. PubMed ID: 35023931
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation mechanisms of the first sphingosine-1-phosphate receptor.
    Caliman AD; Miao Y; McCammon JA
    Protein Sci; 2017 Jun; 26(6):1150-1160. PubMed ID: 28370663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.